Medicare Advantage Add-Only Chart Reviews and In-Home Assessments: Compliance Risks Flagged by OIG

Why OIG, CMS, and DOJ are scrutinizing Medicare Advantage chart reviews and in-home health risk assessments, what changed for 2027 risk adjustment, the major False Claims Act settlements, and how providers and plans can manage compliance risk.

KNOWLEDGE CENTER

11/15/202612 min read

Medicare Advantage (MA) plans are paid more for enrollees with more serious health conditions. The diagnoses that drive those payments usually come from encounters with providers, but plans also add diagnoses through two other sources: chart reviews, in which plans or vendors review medical records to identify diagnoses that were not submitted, and health risk assessments (HRAs), often performed in enrollees' homes by clinicians employed or contracted by plans or vendors.

For years, the HHS Office of Inspector General (OIG) has warned that these sources are vulnerable to misuse. OIG reported in 2019 that diagnoses reported only on chart reviews generated billions in risk-adjusted payments, and in 2020 that diagnoses reported only on HRAs did the same. In October 2024, OIG found that diagnoses reported only on HRAs and HRA-linked chart reviews, and not on any other 2022 service records, resulted in an estimated $7.5 billion in MA risk-adjusted payments for 2023, with in-home HRAs and related chart reviews generating an estimated $4.2 billion of that total. OIG also found that 1.7 million enrollees had these diagnoses with no other encounter records showing visits, procedures, tests, or supplies for them.

A particular concern is the practice known as add-only chart review, in which a plan uses chart reviews to add diagnoses that increase payment but does not use the same reviews to delete diagnoses that are not supported. The Department of Justice (DOJ) has pursued False Claims Act cases involving chart reviews, in-home assessments, and medical record addenda, culminating in a $556 million settlement with Kaiser Permanente affiliates in January 2026, the largest MA risk adjustment settlement to date. CMS has also acted: beginning with 2027 payments, CMS will exclude diagnoses from unlinked chart review records from risk score calculations, with a limited exception.

This article explains the concerns, the enforcement landscape, the policy changes, and what providers and plans should do to manage compliance risk. It is educational and not legal advice.

How Chart Reviews and HRAs Work

Chart Reviews

MA organizations submit diagnoses to CMS through encounter data. When a plan reviews medical records after an encounter and identifies additional diagnoses, it can submit those diagnoses on a chart review record. Chart review records may be linked to a specific encounter already submitted, or unlinked, meaning not tied to a specific encounter. Plans can also use chart review records to delete diagnoses that are not supported.

Health Risk Assessments

HRAs are assessments of an enrollee's health status, often performed by nurse practitioners or physicians. In-home HRAs are conducted at the enrollee's residence. Plans use HRAs for care planning and to identify unmet needs, and diagnoses documented during HRAs that involve face-to-face encounters with acceptable providers may be submitted for risk adjustment. HRA-linked chart reviews are chart reviews that rely on HRA documentation to add diagnoses.

Why These Sources Matter

According to OIG's 2024 report, each in-home HRA generated an estimated $1,869 in risk-adjusted payments, far more than typical office visits. Because these diagnoses can significantly increase payments, they create financial incentives that may lead to inaccurate coding or diagnoses that are not relevant to the enrollee's care.

What OIG Found

2019 and 2020 Reports

OIG's December 2019 report found that diagnoses reported only on chart reviews, and not on any service records, generated an estimated $6.7 billion in risk-adjusted payments for 2017. OIG's September 2020 report found that diagnoses reported only on HRAs, and not on any other service records, generated an estimated $2.6 billion for 2017. OIG raised concerns that these diagnoses might be unsupported or that enrollees were not receiving care for serious conditions.

2024 Report

OIG's October 2024 report, Medicare Advantage: Questionable Use of Health Risk Assessments Continues To Drive Up Payments to Plans by Billions, examined 2022 encounter data and found:

• Diagnoses reported only on HRAs and HRA-linked chart reviews resulted in an estimated $7.5 billion in MA risk-adjusted payments for 2023.

• In-home HRAs and HRA-linked chart reviews generated almost two-thirds of that amount.

• Most MA organizations, 157 of 170, received risk-adjusted payments from these sources for 1.7 million enrollees with no other encounter records containing the diagnoses.

• A small number of health conditions drove most of the payments.

• One large MA company stood out from its peers in its use of in-home HRAs and HRA-linked chart reviews.

OIG said the lack of follow-up visits, procedures, tests, or supplies raised concerns that either the diagnoses were inaccurate and led to improper payments, or enrollees did not receive needed care for serious conditions. OIG recommended that CMS impose additional restrictions on the use of diagnoses reported only on in-home HRAs or related chart reviews, conduct audits to validate these diagnoses, and determine whether certain conditions are more susceptible to misuse. CMS did not concur with the recommendation to restrict use of these diagnoses at that time.

CMS's 2027 Policy Change

In its CY 2027 Rate Announcement, released April 6, 2026, CMS finalized a policy to exclude diagnoses from unlinked chart review records from risk score calculations beginning in 2027, with an exception for beneficiaries who switch from one MA organization to another. CMS explained that unlinked chart review records are not tied to a documented service and expected the payment impact to be greater for organizations that rely more heavily on them. CMS also finalized the exclusion of diagnoses from audio-only services.

For plans and providers, the practical effect is that diagnoses identified through retrospective chart review must generally be tied to a documented encounter to count for payment. This places more emphasis on accurate documentation and coding at the point of care and on linking chart review findings to specific encounters.

The 2027 change does not restrict diagnoses from in-home HRAs that meet risk adjustment requirements, and it does not eliminate the compliance concerns OIG raised about HRAs. Those diagnoses must still be accurate and supported.

The Add-Only Problem

When a plan reviews medical records, it may find both diagnoses that were missed and diagnoses that were submitted but are not supported. A plan that uses reviews only to add diagnoses, without deleting unsupported ones, can systematically inflate risk scores. DOJ has taken the position in False Claims Act litigation that MA organizations have an obligation to submit accurate data and to delete diagnoses they know are unsupported, and that knowingly retaining overpayments resulting from unsupported diagnoses can create liability.

Under 42 CFR 422.326, MA organizations must report and return overpayments they identify. CMS has reminded plans that this obligation continues after a contract ends. Chart review programs designed only to add diagnoses, without a process to identify and delete unsupported ones, create significant risk under these rules.

The Enforcement Landscape

DOJ and whistleblowers have pursued numerous False Claims Act cases involving MA risk adjustment. Notable resolutions include:

• Kaiser Permanente affiliates, January 2026. Five Kaiser affiliates agreed to pay $556 million to resolve allegations that they submitted invalid diagnosis codes. The government alleged that Kaiser pressured physicians to add diagnoses after patient visits through addenda to medical records, set aggressive internal targets, and tied physician and facility financial incentives to risk adjustment goals. Kaiser did not admit liability.

• Independent Health, 2024. Independent Health agreed to pay up to $100 million to resolve allegations involving a chart review program that allegedly added unsupported diagnoses.

• Cigna, 2023. Cigna agreed to pay $172 million to resolve allegations involving diagnoses from in-home assessments that were allegedly unsupported or not followed by care.

• Martin's Point Health Care, 2023. Martin's Point agreed to pay $22.5 million to resolve allegations involving chart reviews that allegedly added unsupported diagnoses.

Other litigation involving large MA organizations remains pending. The cases share common themes: diagnoses added after the fact, financial incentives tied to coding, in-home assessments that generated diagnoses without follow-up care, and failure to delete unsupported diagnoses.

Risks for Providers

Although MA organizations submit risk adjustment data to CMS, providers can face risk in several ways:

• Medical record addenda. Physicians asked to add diagnoses to records after visits, particularly through queries from plans or vendors, may face scrutiny if the addenda are not clinically supported or timely.

• Coding queries. Queries that lead physicians toward specific diagnoses can create risk if not compliant with accepted query practices.

• Incentive programs. Bonuses or other incentives tied to diagnosis capture may suggest that coding is driven by payment rather than clinical care.

• In-home assessments. Clinicians performing HRAs for plans or vendors must document diagnoses accurately and only when clinically supported, and should ensure enrollees are referred for follow-up care.

• Risk-sharing arrangements. Providers in capitated or value-based arrangements that share in risk adjustment revenue may be viewed as participants in coding practices.

• Vendor relationships. Providers who contract with risk adjustment vendors share responsibility for the accuracy of resulting diagnoses.

Federal law also requires providers to report and return identified overpayments within 60 days under section 1128J(d) of the Social Security Act, which can apply in risk adjustment arrangements.

Compliance Practices for Plans and Providers

Two-Way Chart Reviews

Chart review programs should identify and delete unsupported diagnoses as well as add supported ones. Document the methodology, track deletions alongside additions, and audit the program regularly.

Linking Diagnoses to Encounters

In light of the 2027 policy, make sure diagnoses identified through chart review are linked to documented encounters, and that the encounter documentation supports the diagnosis.

Compliant Addenda and Queries

Addenda should be made only when clinically appropriate, within a reasonable time after the encounter, and in accordance with medical record policies. Queries should be non-leading, offer clinically reasonable options including the option that no additional diagnosis applies, and be documented.

In-Home Assessment Safeguards

For in-home HRA programs:

• Use qualified clinicians and document face-to-face encounters thoroughly.

• Document diagnoses only when supported by the clinician's assessment, with evidence such as examination findings, test results, or medication use.

• Avoid diagnoses based solely on patient report or prior records without assessment.

• Refer enrollees for follow-up care for newly identified or uncontrolled conditions and track whether follow-up occurs.

• Monitor diagnosis patterns, especially for conditions OIG identified as driving payments.

• Audit HRA documentation regularly.

Incentive Structures

Avoid compensation or incentives tied to diagnosis capture or risk scores. Tie incentives to quality, care coordination, and documentation accuracy instead.

Vendor Oversight

Oversee risk adjustment vendors closely. Review their methodologies, require two-way reviews, audit their work, and ensure contracts require compliance with CMS rules.

Internal Audits

Regularly audit diagnoses submitted for risk adjustment against medical records, focusing on high-risk conditions and sources. Correct errors and return overpayments.

Training

Train clinicians and coders on risk adjustment documentation, compliant queries and addenda, and the legal risks of inaccurate coding.

Responding to Plan or Vendor Requests

Providers frequently receive requests from plans or vendors to review records, respond to queries, sign attestations, or add diagnoses. Providers should:

• Respond only with clinically accurate information.

• Decline to add diagnoses that are not supported by the clinical record.

• Follow organizational query and addenda policies.

• Document all communications.

• Escalate concerns about aggressive requests to compliance.

Common Mistakes

• Running chart reviews that only add diagnoses.

• Allowing addenda made long after visits to support diagnoses.

• Using leading queries.

• Tying incentives to risk scores.

• Performing in-home assessments without follow-up care.

• Failing to oversee vendors.

• Ignoring the 2027 unlinked chart review exclusion.

Preparing for Audits of These Diagnoses

OIG recommended that CMS audit diagnoses reported only on in-home HRAs and HRA-linked chart reviews, and CMS's expanded Risk Adjustment Data Validation audits now cover all eligible MA contracts. Plans and providers should expect that diagnoses from these sources will be examined closely. To prepare:

• Identify diagnoses submitted only from chart reviews or HRAs, especially for high-payment conditions.

• Confirm that each is supported by a face-to-face encounter by an acceptable provider, documented with evidence of assessment.

• Confirm that chart review diagnoses are linked to the supporting encounter.

• Review whether enrollees received follow-up care for conditions identified during in-home assessments.

• Delete diagnoses that are not supported and return any resulting overpayments.

Conditions That Deserve Extra Attention

OIG found that a small number of conditions drove most of the payments from diagnoses reported only on HRAs and HRA-linked chart reviews. Organizations should focus internal audits on conditions that are frequently identified in home settings but rarely followed by treatment, conditions that require specific testing to diagnose, and conditions whose documentation commonly lacks evidence of evaluation or treatment. For each, confirm that documentation shows how the diagnosis was established and how it is being managed. Diagnoses based on a single assessment without supporting tests, medications, or follow-up should be reviewed carefully.

Governance and Oversight

Risk adjustment compliance requires leadership attention. Boards and compliance committees should receive regular reports on chart review and HRA programs, including the number of diagnoses added and deleted, audit results, vendor performance, and follow-up care rates. Compliance officers should have authority to pause or modify programs that raise concerns. Organizations should also maintain a process for employees to raise concerns without fear of retaliation, since many False Claims Act cases in this area began with whistleblowers who were employees or contractors.

Documentation Standards for Risk Adjustment

Accurate risk adjustment depends on documentation that shows each diagnosis was evaluated during a qualifying encounter. Coders often summarize this standard with the acronym MEAT: the condition was monitored, evaluated, assessed or addressed, or treated. Documentation should include the clinician's assessment of the condition's status, supporting evidence such as examination findings or test results, and the plan of care. Problem lists and historical diagnoses alone generally do not support current-year risk adjustment.

Lessons From Enforcement Actions

The settlements and allegations in recent cases point to practical lessons. Programs that reviewed records only to find new diagnoses, rather than to confirm accuracy, drew scrutiny. So did programs that asked physicians to sign addenda long after visits, set targets for diagnosis capture, or paid incentives tied to coding outcomes. In-home assessment programs that identified serious conditions without connecting enrollees to treatment were also a focus. Organizations can reduce risk by designing programs around accuracy and patient care rather than revenue, documenting the clinical basis for every diagnosis, and monitoring outcomes.

Communicating With Clinicians

Clinicians who perform HRAs or respond to plan queries need clear guidance. Explain that diagnoses must reflect their own clinical assessment, that they should never document a condition they did not evaluate, and that they may decline to add diagnoses they cannot support. Make it easy for clinicians to raise concerns about requests they find inappropriate. Clinicians should also understand that newly identified conditions require follow-up, so assessments should end with clear referrals and communication with the enrollee's primary care provider. Regular feedback from audits helps clinicians see where their documentation is strong and where it needs improvement. Training should be refreshed at least annually and whenever CMS policies change, as they did for 2027, so that clinicians understand which documentation practices support accurate diagnoses and which practices create risk for the organization and its patients. Documenting completion of this training is also valuable evidence of an effective compliance program.

Myths About Chart Reviews and HRAs

Myth: Chart Reviews Are Only About Finding Missed Diagnoses

Compliant chart review programs also identify and delete unsupported diagnoses.

Myth: The 2027 Change Ends Chart Review Risk

CMS excluded unlinked chart review diagnoses from 2027 risk scores, but linked chart reviews and HRAs remain subject to accuracy requirements and enforcement.

Myth: Providers Are Not at Risk Because Plans Submit the Data

Providers who add unsupported diagnoses, participate in incentive programs, or share in risk adjustment revenue can face scrutiny.

Myth: In-Home Assessments Are Inherently Improper

HRAs can support care planning when performed and documented appropriately, with follow-up care for identified conditions.

Questions Leadership Should Ask

• Do our chart reviews delete unsupported diagnoses as well as add new ones?

• Are chart review diagnoses linked to documented encounters?

• Are our queries and addenda compliant and timely?

• Do any incentives depend on diagnosis capture or risk scores?

• Do in-home assessments lead to follow-up care?

• How do we oversee risk adjustment vendors?

Key Takeaways

• OIG has repeatedly found that diagnoses reported only on chart reviews and HRAs generate billions in MA payments, with $7.5 billion for 2023 tied to HRAs and HRA-linked chart reviews alone.

• Add-only chart reviews, which add diagnoses without deleting unsupported ones, create significant compliance and False Claims Act risk.

• DOJ has obtained major settlements involving chart reviews, in-home assessments, and addenda, including $556 million from Kaiser affiliates in 2026.

• Beginning in 2027, CMS excludes diagnoses from unlinked chart review records from risk scores, with an exception for enrollees switching plans.

• Two-way chart reviews, encounter linkage, compliant queries and addenda, follow-up care after HRAs, incentive reform, vendor oversight, and audits are the core compliance safeguards.

How HealthBridge Can Help

HealthBridge helps MA plans, provider groups, and health systems manage risk adjustment compliance. Our team can evaluate chart review and in-home assessment programs, design two-way review processes, assess query and addenda practices, review incentive structures, and audit diagnoses against medical records. We also help organizations prepare for the 2027 unlinked chart review exclusion, strengthen vendor oversight, and train clinicians and coders on compliant documentation. If your organization wants to reduce its risk adjustment compliance exposure, please get in touch with us. We will be happy to help you with this topic.

References

• HHS Office of Inspector General. Medicare Advantage: Questionable Use of Health Risk Assessments Continues To Drive Up Payments to Plans by Billions (OEI-03-23-00380, October 2024). https://oig.hhs.gov/reports/all/2024/medicare-advantage-questionable-use-of-health-risk-assessments-continues-to-drive-up-payments-to-plans-by-billions

• HHS Office of Inspector General. Billions in Estimated Medicare Advantage Payments From Chart Reviews Raise Concerns (OEI-03-17-00470, December 2019). https://oig.hhs.gov/reports/all/2019/billions-in-estimated-medicare-advantage-payments-from-chart-reviews-raise-concerns/

• HHS Office of Inspector General. Billions in Estimated Medicare Advantage Payments From Diagnoses Reported Only on Health Risk Assessments Raise Concerns (OEI-03-17-00474, September 2020). https://oig.hhs.gov/reports/all/2020/billions-in-estimated-medicare-advantage-payments-from-diagnoses-reported-only-on-health-risk-assessments-raise-concerns/

• Centers for Medicare & Medicaid Services. 2027 Medicare Advantage and Part D Rate Announcement Fact Sheet (April 6, 2026). https://www.cms.gov/newsroom/fact-sheets/2027-medicare-advantage-part-d-rate-announcement

• Centers for Medicare & Medicaid Services. CMS Proposes 2027 Medicare Advantage and Part D Payment Policies (January 26, 2026). https://cms.gov/newsroom/press-releases/cms-proposes-2027-medicare-advantage-part-d-payment-policies-improve-payment-accuracy-sustainability

• Centers for Medicare & Medicaid Services. Reminder of Existing Requirements to Report and Return Risk Adjustment Overpayments. https://www.cms.gov/files/document/reminder-report-return-ra-overpayments-non-active-contracts-g.pdf

• U.S. Department of Justice, U.S. Attorney's Office for the District of Colorado. Kaiser Permanente Affiliates Pay $556M to Resolve False Claims Act Allegations (January 14, 2026). https://www.justice.gov/usao-co/pr/kaiser-permanente-affiliates-pay-556m-resolve-false-claims-act-allegations

• U.S. Department of Justice. Cigna Group to Pay $172 Million to Resolve False Claims Act Allegations (September 30, 2023). https://www.justice.gov/opa/pr/cigna-group-pay-172-million-resolve-false-claims-act-allegations

• U.S. Department of Justice. Medicare Advantage Provider Independent Health to Pay Up To $100M to Settle False Claims Act Suit (December 20, 2024). https://www.justice.gov/opa/pr/medicare-advantage-provider-independent-health-pay-100m-settle-false-claims-act-suit

• U.S. Department of Justice. Martin's Point Health Care Inc. to Pay $22.485 Million to Resolve False Claims Act Allegations (July 31, 2023). https://www.justice.gov/opa/pr/martins-point-health-care-inc-pay-22485-million-resolve-false-claims-act-allegations

• Electronic Code of Federal Regulations. 42 CFR 422.310, Risk adjustment data. https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-B/part-422/subpart-G/section-422.310

• Electronic Code of Federal Regulations. 42 CFR 422.326, Reporting and returning of overpayments. https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-B/part-422/subpart-G/section-422.326

• U.S. Code. 31 U.S.C. 3729, False claims. https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title31-section3729

• U.S. Code. 42 U.S.C. 1320a-7k(d), Reporting and returning of overpayments. https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section1320a-7k

Some or all of the services described herein may not be permissible for HealthBridge US clients and their affiliates or related entities.

The information provided is general in nature and is not intended to address the specific circumstances of any individual or entity. While we strive to offer accurate and timely information, we cannot guarantee that such information remains accurate after it is received or that it will continue to be accurate over time. Anyone seeking to act on such information should first seek professional advice tailored to their specific situation. HealthBridge US does not offer legal services.

HealthBridge US is not affiliated with any department of public health agencies in any state, nor with the Centers for Medicare & Medicaid Services (CMS). We offer healthcare consulting services exclusively and are an independent consulting firm not affiliated with any regulatory organizations, including but not limited to the Accrediting Organizations, the Centers for Medicare & Medicaid Services (CMS), and state departments. HealthBridge is an anti-fraud company in full compliance with all applicable federal and state regulations for CMS, as well as other relevant business and healthcare laws. The badges, icons, and achievement graphics displayed on this website represent proprietary performance metrics, volume milestones, and internal corporate recognition issued exclusively by our corporate affiliate network at SummitRidge. These visual markers are utilized solely as historical indicators of enterprise growth, operational longevity, and volume-based milestones cleared within our shared corporate ecosystem.

© 2026 HealthBridge US, a California corporation. All rights reserved.

For more information about the structure of HealthBridge, visit www.myhbconsulting.com/governance

Legal

Resources